Abstract 1016: The androgen receptor splice variant AR-V7 associates with the glucocorticoid receptor following androgen blockade

Abstract 1016: The androgen receptor splice variant AR-V7 associates with the glucocorticoid receptor following androgen blockade

10.1158/1538-7445.am2019-1016 ◽

2019 ◽

Author(s):

Eric Bueter ◽

David Hosfield ◽

Erin McAuley ◽

Phillip Selman ◽

Geoffrey Greene ◽

...

Keyword(s):

Androgen Receptor ◽

Glucocorticoid Receptor ◽

Splice Variant ◽

Androgen Receptor Splice Variant ◽

Androgen Blockade

High Content Analysis of an Androgen Receptor Splice Variant Found in Late-Stage Prostate Cancer

10.1210/endo-meetings.2011.part3.p17.p3-33 ◽

2011 ◽

pp. P3-33-P3-33

Author(s):

Adam T Szafran ◽

Sanjay Mediwala ◽

Marco Marcelli ◽

Michael Mancini

Keyword(s):

Prostate Cancer ◽

Content Analysis ◽

Androgen Receptor ◽

Late Stage ◽

Splice Variant ◽

High Content Analysis ◽

The association between androgen receptor splice variant 7 status and prognosis of metastatic castration‐resistant prostate cancer: A systematic review and meta‑analysis

Andrologia ◽

10.1111/and.13642 ◽

2020 ◽

Vol 52 (7) ◽

Author(s):

Jiatong Zhou ◽

Ranlu Liu

Keyword(s):

Prostate Cancer ◽

Systematic Review ◽

Androgen Receptor ◽

Splice Variant ◽

Meta Analysis ◽

Castration Resistant ◽

Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer

European Urology ◽

10.1016/j.eururo.2019.04.006 ◽

2019 ◽

Vol 76 (5) ◽

pp. 676-685 ◽

Cited By ~ 22

Author(s):

Adam Sharp ◽

Jon C. Welti ◽

Maryou B.K. Lambros ◽

David Dolling ◽

Daniel Nava Rodrigues ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Tumour Cell ◽

Splice Variant ◽

Clinical Utility ◽

Castration Resistant ◽

Circulating Tumour Cell ◽

Abstract 2148: Exploitation of androgen receptor splice variant signaling by guanine nucleotide exchange factor Vav3 in castration resistant prostate cancer

10.1158/1538-7445.am2012-2148 ◽

2012 ◽

Cited By ~ 1

Author(s):

Stephanie Peacock ◽

Cale Fahrenholtz ◽

Kerry L. Burnstein

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Splice Variant ◽

Guanine Nucleotide ◽

Nucleotide Exchange ◽

Guanine Nucleotide Exchange ◽

Castration Resistant ◽

Nucleotide Exchange Factor ◽

Abstract 2910: Androgen receptor splice variant-7 predicts resistance to enzalutamide in patients with castration-resistant prostate cancer

10.1158/1538-7445.am2014-2910 ◽

2014 ◽

Cited By ~ 1

Author(s):

Emmanuel S. Antonarakis ◽

Changxue Lu ◽

Hao Wang ◽

Brandon Luber ◽

Mary Nakazawa ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Splice Variant ◽

Castration Resistant ◽

Abstract LB-26: Androgen receptor splice variant AR3 promotes prostate cancer via modulating expression of autocrine/paracrine factors

10.1158/1538-7445.am2014-lb-26 ◽

2014 ◽

Author(s):

Yun Qiu ◽

Feng Sun ◽

Xi Yang

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Splice Variant ◽

Paracrine Factors ◽

Improving the Nuclear-Localized Androgen Receptor Splice Variant 7 Test—In Reply

JAMA Oncology ◽

10.1001/jamaoncol.2018.6686 ◽

2019 ◽

Vol 5 (3) ◽

pp. 434

Author(s):

Pascal Bamford ◽

Ryan Dittamore ◽

Howard I. Scher

Keyword(s):

Androgen Receptor ◽

Splice Variant ◽

Use of nuclear-localized androgen receptor splice variant 7 protein in CTCs after 1st androgen receptor signaling inhibitor (ARSi) as a predictive biomarker for overall survival on a second ARSi or taxane chemotherapy in metastatic castration-resistant prostate cancer (mCRPC)

Annals of Oncology ◽

10.1093/annonc/mdy284.045 ◽

2018 ◽

Vol 29 ◽

pp. viii292-viii293

Author(s):

H.I. Scher ◽

R.P. Graf ◽

M. Hulling ◽

E. Carbone ◽

R. Dittamore

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Androgen Receptor ◽

Splice Variant ◽

Predictive Biomarker ◽

Androgen Receptor Signaling ◽

Castration Resistant ◽

Androgen Receptor Splice Variant ◽

Taxane Chemotherapy

Reply to Julie Steinestel, Christof Bernemann, Andres J. Schrader, and Jochen K. Lennerz's Letter to the Editor re: Emmanuel S. Antonarakis, Changxue Lu, Brandon Luber, et al. Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men with Metastatic Castration-resistant Prostate Cancer Treated with First- and Second-line Abiraterone and Enzalutamide. J Clin Oncol 2017;35:2149–56. AR-V7 Testing: What's in it for the Patient?

European Urology ◽

10.1016/j.eururo.2017.06.032 ◽

2017 ◽

Vol 72 (6) ◽

pp. e170-e171 ◽

Cited By ~ 1

Author(s):

Jun Luo ◽

Brandon Luber ◽

Hao Wang ◽

Emmanuel S. Antonarakis

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Clin Oncol ◽

Tumor Cells ◽

Clinical Significance ◽

Splice Variant ◽

Second Line ◽

Castration Resistant ◽